[NEU] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
29-Dec-2023
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 85,270.11%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 231,925 14,553 3,197 717 495 13,990 631 167.52%
PBT 205,140 -680 -10,991 -9,910 -11,311 3,073 2,657 106.28%
Tax 48,059 -864 -3,197 -717 -495 -446 -631 -
NP 157,081 184 -7,794 -9,193 -10,816 3,073 3,288 90.43%
Tax Rate -23.43% - - - - 14.51% 23.75% -
Total Cost 74,844 14,369 10,991 9,910 11,311 10,917 -2,657 -
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 67.73 1.26 -243.79 -1,282.15 -2,185.05 21.97 521.08 -28.81%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 1.24 0.00 -0.07 -0.09 -0.11 0.03 0.04 77.19%
EPS Diluted 1.20 0.00 -0.07 -0.09 -0.11 0.03 0.04 76.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.